Respiratory Health Association (RHA) is pleased to name Ravi Kalhan, MD, MS, Director of the Northwestern Asthma and Chronic Obstructive Pulmonary Disease (COPD) Program, as recipient of the 2019 Solovy Award for Advancement in COPD.
Dr. Kalhan additionally serves as director of the Alpha-1-Antitrypsin Deficiency Clinical Resource Center at Northwestern and medical director of the lung volume reduction surgery (LVRS) program. Dr. Kalhan’s clinical interests are in the care of patients with both asthma and COPD as well as alpha-1-antitrypsin deficiency. His research interests relate to respiratory epidemiology, in particular, identification of early risk factors that impact the vulnerability of certain cigarette smokers to develop COPD. He is also involved in clinical trials of new therapies for both asthma and COPD.
Dr. Kalhan additionally serves as Chairman of the Illinois COPD Coalition, a multidisciplinary group, including representatives from community-based organizations, public health departments, professional organizations, patients, caregivers, healthcare providers, pharmaceutical companies and home healthcare providers. They have the goal of implementing sustainable solutions for reducing the burden of COPD in Illinois.
The 2019 Solovy Award was presented to Dr. Kalhan by RHA board member Kathleen Hart Solovy as part of RHA’s year-end reception on June 27, 2019. Funding for the award is provided by the Kathleen Hart Solovy and Jerold S. Solovy Endowment for COPD.
Each year Respiratory Health Association awards early-stage research grants to promising projects covering lung diseases such as lung cancer, idiopathic pulmonary fibrosis, and chronic obstructive pulmonary disease (COPD). Learn more about RHA’s research program and funding opportunities.